Archive 1995–2023

The article reviews published research on the diagnostic and treatment of vertigo especially with using betahistine. Authors also made open study to assess the effect of oral betahistine in 40 patients who had acute vertigo. All these patient were treated for eight weeks by oral administration of betahistine (48 mg daily in three doses). These study confirmed that treatment with betahistine is very effective – after eight weeks of treatment regression of vertigo was achieved in 92.5% patients. The drug was also well tolerated: only 7.5% of patients reported adverse events which were gastric, minor and completely retreat after leave of Betaserc.